Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Strata Critical Medical (SRTAW) Shares Outstanding (Diluted Average) (2019 - 2025)

Historic Shares Outstanding (Diluted Average) for Strata Critical Medical (SRTAW) over the last 7 years, with Q3 2025 value amounting to $82.5 million.

  • Strata Critical Medical's Shares Outstanding (Diluted Average) rose 565.12% to $82.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $82.5 million, marking a year-over-year increase of 565.12%. This contributed to the annual value of $77.5 million for FY2024, which is 540.63% up from last year.
  • Per Strata Critical Medical's latest filing, its Shares Outstanding (Diluted Average) stood at $82.5 million for Q3 2025, which was up 565.12% from $81.3 million recorded in Q2 2025.
  • Over the past 5 years, Strata Critical Medical's Shares Outstanding (Diluted Average) peaked at $82.5 million during Q3 2025, and registered a low of $26.1 million during Q1 2021.
  • In the last 5 years, Strata Critical Medical's Shares Outstanding (Diluted Average) had a median value of $75.8 million in 2024 and averaged $70.7 million.
  • Data for Strata Critical Medical's Shares Outstanding (Diluted Average) shows a peak YoY increase of 17117.46% (in 2022) and a maximum YoY decrease of 829.86% (in 2022) over the last 5 years.
  • Quarter analysis of 5 years shows Strata Critical Medical's Shares Outstanding (Diluted Average) stood at $77.7 million in 2021, then decreased by 8.3% to $71.2 million in 2022, then rose by 3.21% to $73.5 million in 2023, then grew by 5.41% to $77.5 million in 2024, then increased by 6.39% to $82.5 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $82.5 million for Q3 2025, versus $81.3 million for Q2 2025 and $79.9 million for Q1 2025.